We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2024
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Advanced NMR Analysis Helps to Fine-tune Cell Culture Growth Conditions

By LabMedica International staff writers
Posted on 20 Jul 2011
Biotech researchers can optimize cell culture-growth conditions by sending samples of culture-growth media for sophisticated nuclear magnetic resonance (NMR) analysis that can identify metabolites that are consumed and beneficial or toxic products that are produced.

The “Spedia-NMR” NMR analysis service is provided by Spinnovation (Nijmegen, The Netherlands). The analysis service identifies a wide selection of feed components, metabolites, and toxic compounds in culture media. By comparing media profiles from different cell culture batches, Spedia-NMR identifies how a cell consumes and metabolizes the media along the culture process. Investigators usually receive results within five working days.

Image: Cell culture media samples can be rapidly analyzed to provide unequivocal results (Photo courtesy of Claire England, Kapler Communications).
Image: Cell culture media samples can be rapidly analyzed to provide unequivocal results (Photo courtesy of Claire England, Kapler Communications).

Spedia-NMR was designed to perform rapid, high throughput analyses of cell culture media batches and feed-batches in a very cost-efficient manner, using fully automated sample analysis and data processing. The technology - which has been successfully applied to cell types as varied as CHO (Chinese hamster ovary), stem cells, and virus production platforms - is available to all biotech investigators on a fee-for-sample basis or as a contract service.

Dr. Frederic Girard the CEO of Spinnovation said, “In the short term, Spedia-NMR will fill the gap in knowledge to strengthen and speed up cell-culture development and upstream processing… clients need to know what is going on in their cell culture and they need to know it fast. In the mid-term we will be able to provide methods and tools to our clients to help them to cope with the demand of FDA edicts regarding Quality by Design (QbD) and validation in the production environment.”

Related Links:
Eurofins Spinnovation Analytical B.V



Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Automated Blood Typing System
IH-500 NEXT
New
Progesterone Serum Assay
Progesterone ELISA Kit
New
Human Immunodeficiency Virus Assay
RealLine HIV Quantitative Kit

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries